Prognostic Effect of Basal-Like Breast Cancers Is Time Dependent: Evidence From Tissue Microarray Studies on a Lymph Node-Negative Cohort

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-4543
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?

Journal of Oncology
Oncology
2020English

Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer

PLoS ONE
Multidisciplinary
2014English

Cyclin E1 Is a Strong Prognostic Marker for Death From Lymph Node Negative Breast Cancer. A Population-Based Case-Control Study

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2015English

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers

PLoS ONE
Multidisciplinary
2012English

Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2013English

Triple-Negative (Basal-Like) Breast Cancer: A New Entity

Breast Cancer Research
Cancer ResearchOncology
2007English

The Prognostic Value of Lymph Nodes Dissection Number on Survival of Patients With Lymph Node-Negative Gastric Cancer

Gastroenterology Research and Practice
HepatologyGastroenterology
2014English

Expression of ALDH1 in Axillary Lymph Node Metastases Is a Prognostic Factor of Poor Clinical Outcome in Breast Cancer Patients With 1–3 Lymph Node Metastases

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2012English

Basal-Like Breast Cancer; Clinicopathological, Molecular, and Prognostic Features

Archives of Breast Cancer
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy